>AAP82271|FEATURES|CARD|multidrug|TolC|reduced permeability to antibiotic|0
MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQS
RFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYD
ATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFS
NNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQG
RSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAY
TYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTS
INQTAATVGLRHRF
>CAA09666|FEATURES|CARD|beta_lactam|KR51_00036950|reduced permeability to antibiotic|0
MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFG
FKGETQINDILTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLY
DVEGWTDILPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQN
AQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARG
DKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAI
SYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGI
STDNIVALGLVYQF
>AAM15533.1|FEATURES|CARD_deepARG|aminoglycoside|PvrR|resistance by absence|0
MSWKSYRVLVVEDQPFQREYLLNLFRERGVQYLVGAGDGAEALRCLKQDRFDLILSDLMM
PGMDGIQMILQLPYLKHRPKLALMSSSSQRMMLSASRVAQSLGLSVIDLLPKPTLPKAIG
QLLEHLERCLRQKLEPETDETPHGRTALLDALHNEQLVTWFQAKKSLHTGRIVGAEALIR
WSHPQHGLLLPSCFMSDVDATGLHEALLWRVLEQTLNAQESWRRAGYEIPVSVNLPPHLL
DNQELPDRLYEYVGARGACTSSLCFELTESSVTTLSSNYYAGACRLRMKGFGLAQDDFGQ
GYSSFYNLVTTPFTELKIDRSLVQGCVEDNGLNAAVISCIELGHRLNLDVVAEGVETCEE
LNLLRRLGCDRAQGFLISKAVSAREFERQLREDGPSLLV
>NP_415449.1|FEATURES|CARD|multidrug|ompF|reduced permeability to antibiotic|0
MMKRNILAVIVPALLVAGTANAAEIYNKDGNKVDLYGKAVGLHYFSKGNGENSYGGNGDM
TYARLGFKGETQINSDLTGYGQWEYNFQGNNSEGADAQTGNKTRLAFAGLKYADVGSFDY
GRNYGVVYDALGYTDMLPEFGGDTAYSDDFFVGRVGGVATYRNSNFFGLVDGLNFAVQYL
GKNERDTARRSNGDGVGGSISYEYEGFGIVGAYGAADRTNLQEAQPLGNGKKAEQWATGL
KYDANNIYLAANYGETRNATPITNKFTNTSGFANKTQDVLLVAQYQFDFGLRPSIAYTKS
KAKDVEGIGDVDLVNYFEVGATYYFNKNMSTYVDYIINQIDSDNKLGVGSDDTVAVGIVY
QF
>AAB57788.1|FEATURES|CARD|rifampin|rphB|reduced permeability to antibiotic|0
MKKSLIALTLAALPVAATADVTLYGAIKAGVQTYRSVEHTKGKVSKVETGSEIADFGSKI
GFKGQEDLGNGLKAVWQLEQGASVAGTNTGWGNKQSFVGLKGGFGTIRAGSLNSPLKNTG
ANVNAWESGKFTGNVLEISGMAQREHRYLSVRYDSPEFAGFSGSVQYAPKDNSGSNGESY
HVGLNYRNNGFFAQYAGLFQRYGEGTKKIEYEHQVYSIPSLFVEKLQVHRLVGGYDNNAL
YVSVAAQQQDAKLYGARRANSHNSQTEVAATAAYRFGNVTPRVSYAHGFKGTVDSADHDN
TYDQVVVGAEYDFSKRTSALVSAGWLQEGKGADKIVSTASAVVLRHKF
>YP_001844878|FEATURES|ARDB_deepARG|beta_lactam|oprD|resistance by absence|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATLAVLISAAIISSAQASEQSEA
KGFVEDANGSILFRTGYLTRDKKQGAKDTSSVAQSAIVSIESGFTPGIVGFGVGVVGDGS
FKIGENKNAGNQMIPKHNDGSAYDHWARGGGSVKARFSNTTVRYGTQVLDLPVLASNTGR
MVPEYFTGTLLTSHEIKNLEVVAGKFTKDQMSDQINTDADASGRGLDRAIVWGAKYKFND
NLNASYYGLDSKNALERHYANVNFKQPLANDSSLTYDFSGYHTKFDANAHTYSATGTVAP
NYAADGIAGEEKTNNIWAISGTYATGPHSVMLAYQQNTGNVGYDYGQNADGFQSIYLPNS
YMSDFIGNHEKSAQIQYNVDFGKLGVLPGLNWTTAFVYGWDIKVRNVTDDAQEREFFNQV
KYTVQSGFAKDASLRIRNSYYRASDAYQGAYIGDTNEWRIFLDIPVKLF
>NP_249649.1|FEATURES|CARD|aminoglycoside|APH(3')-Ia|reduced permeability to antibiotic|0
MKVMKWSAIALAVSAGSTQFAVADAFVSDQAEAKGFIEDSSLDLLLRNYYFNRDGKSGSG
DRVDWTQGFLTTYESGFTQGTVGFGVDAFGYLGLKLDGTSDKTGTGNLPVMNDGKPRDDY
SRAGGAVKVRISKTMLKWGEMQPTAPVFAAGGSRLFPQTATGFQLQSSEFEGLDLEAGHF
TEGKEPTTVKSRGELYATYAGETAKSADFIGGRYAITDNLSASLYGAELEDIYRQYYLNS
NYTIPLASDQSLGFDFNIYRTNDEGKAKAGDISNTTWSLAAAYTLDAHTFTLAYQKVHGD
QPFDYIGFGRNGSGAGGDSIFLANSVQYSDFNGPGEKSWQARYDLNLASYGVPGLTFMVR
YINGKDIDGTKMSDNNVGYKNYGYGEDGKHHETNLEAKYVVQSGPAKDLSFRIRQAWHRA
NADQGEGDQNEFRLIVDYPLSIL
>BAA02945|FEATURES|ARDB_deepARG|tunicamycin|tmrB|reduced permeability to antibiotic|0
MAMIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLW
RAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKR
LRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRG
SLRRFADRLMVKLNHIRIK
>NP_459974.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MMKRKILAAVIPALLAAATANAAEIYNKDGNKLDLYGKAVGRHVWTTTGDSKNADQTYAQ
IGFKGETQINTDLTGFGQWEYRTKADRAEGEQQNSNLVRLAFAGLKYAEVGSIDYGRNYG
IVYDVESYTDMAPYFSGETWGGAYTDNYMTSRAGGLLTYRNSDFFGLVDGLSFGIQYQGK
NQDNHSINSQNGDGVGYTMAYEFDGFGVTAAYSNSKRTNDQQDRDGNGDRAESWAVGAKY
DANNVYLAAVYAETRNMSIVENTVTDTVEMANKTQNLEVVAQYQFDFGLRPAISYVQSKG
KQLNGAGGSADLAKYIQAGATYYFNKNMNVWVDYRFNLLDENDYSSSYVGTDDQAAVGIT
YQF
>AAK21275.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALQVAGAAYAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFGGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGYQKQNGEGFGTSVTYDIWDGISAGFAYSSSKRTDEQNSVNTRYTDSNGVSR
RVLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGIIGFANKAQNFEVVAQYQFDF
GLRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNVSTYVDYKINLLDDNCFTKDA
SISTDNVVALGLVYQF
>NP_275030.1|FEATURES|megares|multidrug|porB|reduced permeability to antibiotic|0
MKKSLIALTLAALPVAAMADVTLYGTIKAGVETSRSVFHQNGQVTEVTTATGIVDLGSKI
GFKGQEDLGNGLKAIWQVEQKASIAGTDSGWGNRQSFIGLKGGFGKLRVGRLNSVLKDTG
DINPWDSKSDYLGVNKIAEPEARLISVRYDSPEFAGLSGSVQYALNDNAGRHNSESYHAG
FNYKNGGFFVQYGGAYKRHHQVQEGLNIEKYQIHRLVSGYDNDALYASVAVQQQDAKLTD
ASNSHNSQTEVAATLAYRFGNVTPRVSYAHGFKGLVDDADIGNEYDQVVVGAEYDFSKRT
SALVSAGWLQEGKGENKFVATAGGVGLRHKF
>ABR76392.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MMKRNILAVVIPALLVAGAANAAEIYNKNGNKLDFYGKMVGEHVWTTNGDTSSDDTTYAR
IGLKGETQINDQLIGYGQWEYNMDASNVEGSQTTKTRLAFAGLKAGEYGSFDYGRNYGAI
YDVEAATDMLVEWGGDGWNYTDNYMTGRTNGVATYRNSDFFGLVDGLSFALQYQGKNDHD
RAIRKQNGDGFSTAATYAFDNGIALSAGYSSSNRSVDQKADGNGDKAEAWATSAKYDANN
IYAAVMYSQTYNMTPEEDNHFAGKTQNFEAVVQYQFDFGLRPSIGYVQTKGQGPAVACWL
LRRRCGSG
>AGS59331.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MFAGAANAAEMYNKDGNKVDIYGKVDVRHYFADADTKGDHESGDASRARIGFKGETQINK
DLTGFGRFEYEVKTNTTEGENKAKTRLAYAGLKFADFGSLDYGRNYGVIYDTNAWTDVLP
LWGGDSMAQTDVYMTSRTTGVLTYRNTDMFGYVDGLSFALQYQGKNNENTNNKRKDNAEA
NGDGFGFSTAYNLGWGVTLGGGYSSSARTNWQEHKSDATGKRAEAWNVGGKFEANNVYLA
AMYGETRNMNYYGDGAIANKTQNIELTAQYDFADLGIKPSLGYVQSKGKDLNNGVGGLKD
NNHDLVKYISVGSFYKFNKNMTAVVDYKINLLDEDDFTKANGVATDNVVGLGLTYQF
>CBA29682.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MKRNILAVVIPALLVAGAANAAEIYNKNGNKLDLYGKVTAEHDFVTSGDNTSNGDATYAQ
LGFKGETQINDQLTGYGQWEYRAYATSAESEQGANNSNRTRLAFAGLKIADAGSIDYGRN
YGIVYDVESYTDMAPSYSGMTWANYSDNFMTGRTTGVLTYRNTGFFGLADGLNFGIQYQG
KNDRDNVATSNGDGVGYSLGYDFGEGFSLIGAYSNSNRTLQQKLDDKGDRAEAWAVGAKY
DANNLYLATVYAETRNMTREADNTFANKTQNFEAIAQYQFDFGLRPSLSYVQSKGKNLTA
RGTFDGGDADLQKYVEVGAYYYFNKNFNVYVDYQINLIDNDAYARNVGIVNGRDDQVALA
ATYQF
>AIA17591.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|reduced permeability to antibiotic|0
ARQELLAYQVRELRALDLKEGEVESLERERLLLANASRIGAGLQKALDRLYDAEELSAND
AIGASLREIAALSPLDPRLEPAVAALELSRIQLQEAADEIRRRLGAVEHDPARHDAVELR
LVAAVDLARKHRAPPERLWALTRDFEQQLDDITASDSRLESISREVDRLRASMRAATEAL
HAARITAARSLGSEVNANLQSLGMVGCSFLVNVDALPVAEAGPDGADQVEFLISTSPGLA
AGPIARIASGGELSRLSLAIQVVAMTANGAPTLIFDEVDAGIGGGVAEIVGQCLQRLSSQ
RQVLCVTHLPQVASQADHHYAVSKAIDETKTCTSVREISGASRVDEIARMLGGIRITART
RDHAREMLKGARPRRAG